- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07498192
Thai Baby Study Phase 1
National Situational Analysis of Birth Mode and Infant Outcomes in Thailand
The goal of this observational study is to examine national trends in mode of delivery and to assess associations between cesarean section and early-life health outcomes using routinely collected health data in Thailand. The study includes mother-infant dyads delivering in public hospitals across Thailand.
The main questions it aims to answer are:
Is cesarean delivery associated with increased risk of adverse neonatal outcomes compared with vaginal delivery?
Is cesarean delivery associated with differences in early-life healthcare utilization and breastfeeding outcomes during the first year of life?
Researchers will compare infants born by cesarean section with infants born by vaginal delivery to evaluate differences in neonatal morbidity, healthcare utilization, and breastfeeding patterns.
Participants will not receive any intervention. The study involves secondary analysis of de-identified national health administrative and clinical data, including delivery records and linked maternal and infant health outcomes.
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Jami Walker, MSc
- Phone Number: 812-429-7299
- Email: jami.walker@reckitt.com
Study Contact Backup
- Name: Amber Jessell
- Phone Number: 812-429-8903
- Email: amber.jessell@reckitt.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Mother-infant dyads with delivery records available in the national health administrative database.
- Deliveries occurring in public hospitals in Thailand during the study period.
- Records containing information on mode of delivery and linked maternal and infant outcomes.
Exclusion Criteria:
- Records with missing or invalid delivery mode information.
- Records that cannot be reliably linked between mother and infant.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Cesarean Delivery Cohort
Mother-infant dyads in which delivery occurred by cesarean section.
This observational cohort is identified retrospectively using routinely collected, de-identified national health data.
No intervention is assigned.
|
|
Vaginal Delivery Cohort
Mother-infant dyads in which delivery occurred by vaginal birth.
This observational cohort is identified retrospectively using routinely collected, de-identified national health data.
No intervention is assigned.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Neonatal health outcomes associated with mode of delivery
Time Frame: Birth to 28 days of life
|
Comparison of neonatal health outcomes, including birth asphyxia, neonatal infection, respiratory complications, and low birth weight, between infants born by cesarean section and vaginal delivery using routinely collected national health data.
|
Birth to 28 days of life
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Early-life healthcare utilization during infancy
Time Frame: Birth to 12 months of age
|
Frequency of healthcare utilization, including outpatient visits, emergency department visits, hospital admissions, and antibiotic use among infants by mode of delivery.
|
Birth to 12 months of age
|
|
Breastfeeding outcomes by mode of delivery
Time Frame: Birth to 12 months of age
|
Rates of exclusive and any breastfeeding among infants born by cesarean section compared with vaginal delivery, assessed using routinely collected health and nutrition records.
|
Birth to 12 months of age
|
|
Temporal and geographic trends in cesarean delivery rates
Time Frame: 2015 to 2025
|
Trends in cesarean section rates across regions, hospital levels, and time periods using national health administrative data.
|
2015 to 2025
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Veronica Fabrizio, DO, Mead Johnson Nutrition
- Principal Investigator: Krit Pongpirul, MD, MPH, PhD, Chulalongkorn University
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 3399-1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Outcome Assessment
-
National Taiwan University HospitalRecruiting
-
Boston Children's HospitalNot yet recruitingPatient Outcome Assessment
-
Moscow Regional Research and Clinical Institute...CompletedPatient Outcome AssessmentRussian Federation
-
University of ZurichCompletedOutcome Assessment, Health CareSwitzerland
-
Derince Training and Research HospitalCompletedPatient Satisfaction | Outcome Assessment
-
Hospital da Luz, PortugalUniversidade Católica PortuguesaCompletedAged | Patient Outcome Assessment | MultimorbidityPortugal
-
RANDActive, not recruitingOutcome Assessment | Maternal Health ServicesNigeria
-
Chang Gung Memorial HospitalUnknownHemodynamic Monitoring | Perioperative Care | Outcome Assessment
-
Technical University of MunichTerminatedRehabilitation | Critical Care | Outcome Assessment (Health Care)Germany
-
National Cancer Institute (NCI)CompletedNeoplasm | Healthcare Disparities | Health Services Accessibility | Outcome AssessmentUnited States